Table 2.
Pathology | n | % | ADC (×10−3 mm2/s) Ave. ± SD. | +p |
---|---|---|---|---|
Malignant | 15 | 46.9 | 0.90 ± 0.17 | 0.001 ** |
Benign | 17 | 53.1 | 1.57 ± 0.42 | |
Lymphoma | 5 | 33.3 | 0.80 ± 0.14 | 0.100 |
Carcinoma | 10 | 66.7 | 0.96 ± 0.17 |
+ Student t test; ** p ≤ 0.001.
Pathology | n | % | ADC (×10−3 mm2/s) Ave. ± SD. | +p |
---|---|---|---|---|
Malignant | 15 | 46.9 | 0.90 ± 0.17 | 0.001 ** |
Benign | 17 | 53.1 | 1.57 ± 0.42 | |
Lymphoma | 5 | 33.3 | 0.80 ± 0.14 | 0.100 |
Carcinoma | 10 | 66.7 | 0.96 ± 0.17 |
+ Student t test; ** p ≤ 0.001.